Product Images Losartan Potassium

The text seems to be showing results of a study labeled "Morihi." It includes data on two medications, Atenolol and Losartan, and their effect on reducing the primary endpoint in a sample of patients. The adjusted risk reduction percentage and p-value are provided. However, there is no available information on the nature of the primary endpoint or the characteristics of the patient sample.*

This is a statistical chart displaying the percentage of patients who had fatal/non-fatal stroke while taking Atenolol versus Losartan. The chart also shows an adjusted risk reduction of 25% with Losartan with a p-value of 0.001. The text at the bottom appears to be a timeline marked in months.*

The text appears to be a table showing the results of a study on the incidence of primary composite stroke (fatal/non-fatal) in patients with different demographics and medical histories. The table includes information on the number of events, hazard ratios, and rates for different patient characteristics such as age, race, and history of cardiovascular disease. The study also appears to compare the effectiveness of two different medications, Losartan and Atenolol, on the incidence of stroke. The figure included shows the primary endpoint events within demographic subgroups.*

This is a statistical analysis report on a sample of patients, where the risk reduction rate is 16.1% and the p-value obtained is 0.022. However, the meaning and context of the word "Menthe" is not clear from the given text.*

This is a description of Losartan Potassium Tablets, USP 100mg with NDC 68645-526-70. It is a prescription drug packaged in 30 tablets. The product is a film-coated tablet containing losartan potassium USP 100 mg. The product should be kept at 25°C (77°F), and the package should not be used if broken, blister card backing is torn, or individual blisters are open. The pharmacist should dispense this product with a patient information leaflet. Dosage information can be found in the accompanying prescribing information. The product is manufactured by Legacy Pharmaceutical Packaging, LLC. It is child-resistant and should not be separated from the protective carton. The product is intended for adults only. The instructions for opening the package are given on the package itself. It also has some color codes and other numbers that could indicate batch or manufacture information.*